Free Review Articles on Heart failure (BASKET)                                 Metatextbook

Freie Reviews über Herzinsuffizienz (allg)                                 Look here for Journal Homepages

  • Heart failure (BASKET)
  • Frusemide
  • Heart failure (acute)
  • Cardiac pacemaker (biventricular)
  • Heart failure (chronical)
  • Heart (Cardiomyoplasty)
  • BNP
  • Urocortin
  • Heart (Artificial)
  • Heart failure (Stage D)
  • Heart (Echocardiography)
  • Acupuncture
  • Heart (Scintigraphy)
  • Heart (MRT)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12000ABC of heart failure. Acute and chronic management strategies.



    		+-nlBMJ 320(7234):559-62 (2000)
    22000ABC of heart failure. Management: digoxin and other inotropes, beta blockers, and antiarrhythmic and antithrombotic treatment.



    		+-nlBMJ 320(7233):495-8 (2000)
    32000ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates.



    		+-nlBMJ 320(7232):428-31 (2000)
    42000ABC of heart failure. Non-drug management.



    		+-nlBMJ 320(7231):366-9 (2000)
    52000ABC of heart failure. Clinical features and complications.



    		+-nlBMJ 320(7229):236-9 (2000)
    62000ABC of heart failure. Pathophysiology.



    		+-nlBMJ 320(7228):167-70 (2000)
    72000ABC of heart failure: aetiology.



    		+-nlBMJ 320(7227):104-7 (2000)
    82000ABC of heart failure. History and epidemiology.



    		+-nlBMJ 320(7226):39-42 (2000)
    91999Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.



    		+-nlBMJ 318(7195):1400-2 (1999)
    101994Diagnosis and management of heart failure.



    		+-nlBMJ 308(6924):321-8 (1994)
    112006Update in the approach to and management of heart failure.



    		+-nlSouth Med J 99(12):1346-55; quiz 1356-7, 1384 (2006)
    122009High output heart failure.



    		+-nlQJM 102(4):235-41 (2009)
    132004Current concepts in the management of heart failure.



    		+-nlCrit Care Resusc 6(1):31-53 (2004)
    142009Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.



    		+-nlEur J Heart Fail 11(2):214-9 (2009)
    152009Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.



    		+-nlCan J Cardiol 25(2):85-105 (2009)
    162008Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.



    		+-nlCan J Cardiol 24(1):21-40 (2008)
    171998Animal models of human cardiovascular disease, heart failure and hypertrophy.



    		+-nlCardiovasc Res 39(1):60-76 (1998)
    182000The acute vascular effects of frusemide in heart failure.



    		+-nlBr J Clin Pharmacol 50(1):9-13 (2000)
    192009Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.



    		+-nlHealth Technol Assess 13(32):1-207, iii (2009)
    202002Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.



    		+-nlAm J Manag Care 8(9 Suppl):18-24 (2002)
    212002Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action.



    		+-nlAm J Manag Care 8(9 Suppl):13-7 (2002)
    221999Disease management of congestive heart failure.



    		+-nlAm J Manag Care 5(4):499-507; quiz 508-9 (1999)
    231998Clinical practice guidelines for heart failure.



    		+-nlAm J Manag Care 4(6 Suppl):S329-37 (1998)
    242006Cardiac resynchronization therapy and adrenergic mechanisms.



    		+-nlAm J Physiol Heart Circ Physiol 291(6):H2590-1 (2006) Bristow MR
    252009Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.



    		+-nlAnn Intern Med 150(11):784-94 (2009)
    262007In the Clinic. Heart failure.



    		+-nlAnn Intern Med 147(11):ITC12-1-ITC12-16 (2007)
    272005Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials.



    		+-nlAnn Intern Med 142(2):132-45 (2005) Yan AT
    282001Beta-blockers in congestive heart failure. A Bayesian meta-analysis.



    		+-nlAnn Intern Med 134(7):550-60 (2001)
    292005Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.



    		+-nlArthritis Res Ther 7(5):195-207 (2005)
    301973Non-invasive methods for the assessment of cardiac function.



    		+-nlCalif Med 119(3):21-37 (1973)
    312004The pulmonary manifestations of left heart failure.



    		+-nlChest 125(2):669-82 (2004)
    322003Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role.



    		+-nlChest 124(3):1090-102 (2003)
    331998A review of why and how we may use beta-blockers in congestive heart failure.



    		+-nlChest 113(3):800-8 (1998)
    341986Prevalence of congestion in chronic heart failure.



    		+-nlChest 90(3):311-2 (1986)
    352009Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?



    		+-nlCirc Heart Fail 2(1):56-62 (2009)
    362003What is the role of beta-adrenergic signaling in heart failure?



    		+-nlCirc Res 93(10):896-906 (2003)
    372008Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.



    		+-nlCirculation 118(8):863-71 (2008)
    382008Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective.



    		+-nlCirculation 117(7):975-83 (2008)
    392008New-onset heart failure in children in the absence of structural congenital heart disease.



    		+-nlCirculation 117(1):11-2 (2008) Webber SA
    402007National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.



    		+-nlCirculation 116(5):e95-8 (2007)
    412007National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.



    		+-nlCirculation 116(5):e99-109 (2007)
    422007Metabolic mechanisms in heart failure.



    		+-nlCirculation 116(4):434-48 (2007)
    432006Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.



    		+-nlCirculation 113(24):2851-60 (2006)
    442006Biomarkers of cardiovascular disease: molecular basis and practical considerations.



    		+-nlCirculation 113(19):2335-62 (2006)
    452005ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America.



    		+-nlCirculation 112(12):1888-916 (2005)
    462005ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.



    		+-nlCirculation 112(12):e154-235 (2005)
    472005ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America.



    		+-nlCirculation 112(12):1853-87 (2005)
    482005Mechanical device-based methods of managing and treating heart failure.



    		+-nlCirculation 112(3):438-48 (2005)
    492005Mechanisms and models in heart failure: the biomechanical model and beyond.



    		+-nlCirculation 111(21):2837-49 (2005)
    502003Cardiac resynchronization therapy for heart failure.



    		+-nlCirculation 108(21):2596-603 (2003)
    512003How do beta-blockers improve ventricular function in patients with congestive heart failure?



    		+-nlCirculation 107(19):2395-7 (2003) Barry WH
    522003Antiadrenergic therapy of chronic heart failure: surprises and new opportunities.



    		+-nlCirculation 107(8):1100-2 (2003)
    532002Sympathetic nervous system in heart failure.



    		+-nlCirculation 106(19):2417-8 (2002)
    542002Contemporary medical options for treating patients with heart failure.



    		+-nlCirculation 105(19):2244-6 (2002)
    552002New therapeutic options in congestive heart failure: Part II.



    		+-nlCirculation 105(18):2223-8 (2002)
    562002New therapeutic options in congestive heart failure: Part I.



    		+-nlCirculation 105(17):2099-106 (2002)
    572002The "unsympathetic" nervous system of heart failure.



    		+-nlCirculation 105(15):1753-5 (2002)
    582001ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.



    		+-nlCirculation 104(24):2996-3007 (2001)
    592000Catecholamines, cardiac beta-adrenergic receptors, and heart failure.



    		+-nlCirculation 101(14):1634-7 (2000)
    602000beta-adrenergic receptor blockade in chronic heart failure.



    		+-nlCirculation 101(5):558-69 (2000)
    611999Mechanisms and models in heart failure: A combinatorial approach.



    		+-nlCirculation 100(9):999-1008 (1999)
    621998Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.



    		+-nlCirculation 98(12):1184-91 (1998)
    632008Evolving concepts of left ventricular hypertrophy.



    		+-nlEur Heart J 29(7):846-8 (2008) Tikhonoff V
    642008Heart failure with preserved ejection fraction: dangerous, elusive, and difficult.



    		+-nlEur Heart J 29(3):285-7 (2008) Nielsen OW
    652006Heart failure therapy: testosterone replacement and its implications.



    		+-nlEur Heart J 27(1):10-2 (2006) Rauchhaus M
    662005The importance of the gastrointestinal system in the pathogenesis of heart failure.



    		+-nlEur Heart J 26(22):2368-74 (2005)
    672005Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.



    		+-nlEur Heart J 26(11):1115-40 (2005)
    682004Expert consensus document on beta-adrenergic receptor blockers.



    		+-nlEur Heart J 25(15):1341-62 (2004)
    692001Refractory heart failure - drugs and devices.



    		+-nlEur Heart J 22(24):2227-30 (2001)
    702000The 6-minute walk. A simple test with clinical application.



    		+-nlEur Heart J 21(7):507-8 (2000)
    712000Beta-blockers continue to surprise us.



    		+-nlEur Heart J 21(5):354-64 (2000)
    721999Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.



    		+-nlEur Heart J 20(16):1182-90 (1999) Bart BA
    731997The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.



    		+-nlEur Heart J 18(5):736-53 (1997)
    741997Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials.



    		+-nlEur Heart J 18(4):560-5 (1997)
    751996Beta-blocking agents in heart failure. Should they be used and how?



    		+-nlEur Heart J 17(11):1629-39 (1996)
    761996Congestive heart failure. Towards a comprehensive treatment.



    		+-nlEur Heart J 17 Suppl B(-):43-56 (1996)
    771996Beta-blockers in heart failure. Future directions.



    		+-nlEur Heart J 17 Suppl B(-):39-42 (1996)
    781996Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.



    		+-nlEur Heart J 17 Suppl B(-):24-9 (1996)
    791996Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the disease.



    		+-nlEur Heart J 17 Suppl B(-):21-3 (1996)
    801996Beta-blockers in heart failure--the evidence from clinical trials.



    		+-nlEur Heart J 17 Suppl B(-):17-20 (1996)
    811996Cardiac adrenergic receptor effects of carvedilol.



    		+-nlEur Heart J 17 Suppl B(-):8-16 (1996)
    822006Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients.



    		+-nlHeart 92(12):1728-31 (2006)
    832005Systematic review of multidisciplinary interventions in heart failure.



    		+-nlHeart 91(7):899-906 (2005) Holland R
    842002Heart failure: aetiology, diagnosis, and treatment.



    		+-nlHeart 88(6):567-9 (2002)
    852001Heart failure: What causes the symptoms of heart failure?



    		+-nlHeart 86(5):574-8 (2001)
    862001Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics.



    		+-nlHeart 85(1):97-103 (2001)
    872000Non-transplant surgery for heart failure.



    		+-nlHeart 83(5):603-10 (2000)
    882000Epidemiology, aetiology, and prognosis of heart failure.



    		+-nlHeart 83(5):596-602 (2000)
    891999Major beta blocker mortality trials in chronic heart failure: a critical review.



    		+-nlHeart 82 Suppl 4(-):IV14-22 (1999)
    901997The origin of symptoms in chronic heart failure.



    		+-nlHeart 78(5):429-30 (1997)
    912006Novel mechanisms of sympathetic regulation in chronic heart failure.



    		+-nlHypertension 48(6):1005-11 (2006)
    922009Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure.



    		+-nlIsr Med Assoc J 11(6):348-53 (2009)
    932009Heart failure--new insights.



    		+-nlIsr Med Assoc J 11(2):105-11 (2009)
    942003Cardiac resynchronization therapy for heart failure shows great promise.



    		+-nlIsr Med Assoc J 5(8):589-91 (2003) Ovsyshcher IE
    952008Anemia and mortality in heart failure patients a systematic review and meta-analysis.



    		+-nlJ Am Coll Cardiol 52(10):818-27 (2008)
    962008Anemia and chronic heart failure implications and treatment options.



    		+-nlJ Am Coll Cardiol 52(7):501-11 (2008)
    972008Vasodilator therapy for decompensated heart failure.



    		+-nlJ Am Coll Cardiol 52(3):208-10 (2008) Yancy CW
    982007Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.



    		+-nlJ Clin Endocrinol Metab 92(1):180-5 (2007)
    992005Altered intracellular Ca2+ handling in heart failure.



    		+-nlJ Clin Invest 115(3):556-64 (2005) Yano M
    1002005Mitochondrial energy metabolism in heart failure: a question of balance.



    		+-nlJ Clin Invest 115(3):547-55 (2005) Huss JM
    1012005Genetic causes of human heart failure.



    		+-nlJ Clin Invest 115(3):518-26 (2005) Morita H
    1022005NO/redox disequilibrium in the failing heart and cardiovascular system.



    		+-nlJ Clin Invest 115(3):509-17 (2005) Hare JM
    1032005Oxygen, oxidative stress, hypoxia, and heart failure.



    		+-nlJ Clin Invest 115(3):500-8 (2005) Giordano FJ
    1042005Learning from failure: congestive heart failure in the postgenomic age.



    		+-nlJ Clin Invest 115(3):495-9 (2005)
    1052001Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown.



    		+-nlJ Clin Invest 107(8):947-8 (2001)
    1061993Beta-adrenergic receptors in heart failure.



    		+-nlJ Clin Invest 92(6):2564 (1993)
    1072009BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.



    		+-nlJAMA 301(4):383-92 (2009)
    1082002beta-Blockers in heart failure: clinical applications.



    		+-nlJAMA 287(7):890-7 (2002)
    1092002beta-Blocker therapy in heart failure: scientific review.



    		+-nlJAMA 287(7):883-9 (2002)
    1102002Medical management of advanced heart failure.



    		+-nlJAMA 287(5):628-40 (2002)
    1111997Arrhythmias and sudden death in heart failure.



    		+-nlJpn Circ J 61(9):727-40 (1997)
    1122000Therapy of heart failure.



    		+-nlKidney Int 57(4):1418-25 (2000)
    1132005Aldosterone receptor antagonists in the medical management of chronic heart failure.



    		+-nlMayo Clin Proc 80(12):1623-30 (2005)
    1142002Beta-blockers in chronic heart failure: considerations for selecting an agent.



    		+-nlMayo Clin Proc 77(11):1199-206 (2002)
    1152002Beta-blockers: new standard therapy for heart failure.



    		+-nlMayo Clin Proc 77(8):839-45; quiz 845-6 (2002)
    1162004Use of diuretics in cardiovascular diseases: (1) heart failure.



    		+-nlPostgrad Med J 80(942):201-5 (2004)
    1172003Drug therapy in chronic heart failure.



    		+-nlPostgrad Med J 79(937):634-42 (2003)
    1182003Mechanisms and management of diuretic resistance in congestive heart failure.



    		+-nlPostgrad Med J 79(931):268-71 (2003)
    1191998Recent advances in the drug treatment of heart failure.



    		+-nlPostgrad Med J 74(877):658-61 (1998)
    1201997The management of congestive heart failure.



    		+-nlPostgrad Med J 73(858):194-200 (1997)
    1211996Diagnosis and management of heart failure in the elderly.



    		+-nlPostgrad Med J 72(852):577-80 (1996)
    1222006Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.



    		+-nlRheumatology (Oxford) 45 Suppl 4(-):iv8-13 (2006)
    1232007End-stage chronic heart failure.



    		+-nlSwiss Med Wkly 137(7-8):107-13 (2007)
    1241999Pathophysiology of heart failure: a look at the future.



    		+-nlTex Heart Inst J 26(1):28-33 (1999)
    1251999Heart failure: Part II.



    		+-nlWest J Med 170(6):339-42 (1999)
    1261991Congestive heart failure. New frontiers.



    		+-nlWest J Med 154(4):427-41 (1991)
    1271990Managing congestive heart failure medically--what have we learned?



    		+-nlWest J Med 153(4):442-4 (1990)
    1281990Medical management of congestive heart failure.



    		+-nlWest J Med 153(4):406-14 (1990)
    1292007The challenge of correcting volume overload in hospitalized patients with decompensated heart failure.



    		+-nlJ Am Coll Cardiol 49(6):684-6 (2007) Elkayam U
    1302006Emerging therapies for the management of decompensated heart failure: from bench to bedside.



    		+-nlJ Am Coll Cardiol 48(12):2397-409 (2006)
    1312005Ultrafiltration: a new approach toward mechanical diuresis in heart failure.



    		+-nlJ Am Coll Cardiol 46(11):2052-3 (2005) Bourge RC
    1322005Vasopressin antagonism in heart failure.



    		+-nlJ Am Coll Cardiol 46(10):1785-91 (2005)
    1332004Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.



    		+-nlJ Am Coll Cardiol 44(6):1308-10 (2004) Weber KT
    1342004Anemia as a risk factor and therapeutic target in heart failure.



    		+-nlJ Am Coll Cardiol 44(5):959-66 (2004)
    1352004Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.



    		+-nlJ Am Coll Cardiol 43(3):317-27 (2004)
    1362003Predicting cardiac resynchronization response by QRS duration: the long and short of it.



    		+-nlJ Am Coll Cardiol 42(12):2125-7 (2003) Kass DA
    1372003Colloid osmotic pressure: an under-recognized factor in the clinical syndrome of heart failure.



    		+-nlJ Am Coll Cardiol 42(4):717-8 (2003) Konstam MA
    1382002The regulation and measurement of plasma volume in heart failure.



    		+-nlJ Am Coll Cardiol 39(12):1901-8 (2002)
    1392001ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).



    		+-nlJ Am Coll Cardiol 38(7):2101-13 (2001)
    1402001Heart failure with preserved systolic function. A different natural history?



    		+-nlJ Am Coll Cardiol 38(5):1277-82 (2001)
    1412000The role of tumor necrosis factor in the pathophysiology of heart failure.



    		+-nlJ Am Coll Cardiol 35(3):537-44 (2000)
    1421999Drug-induced heart failure.



    		+-nlJ Am Coll Cardiol 33(5):1152-62 (1999)
    1431998Etiology and response to drug treatment in heart failure.



    		+-nlJ Am Coll Cardiol 32(5):1167-72 (1998)
    1441997Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.



    		+-nlJ Am Coll Cardiol 30(1):27-34 (1997)
    1451995Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).



    		+-nlJ Am Coll Cardiol 26(5):1376-98 (1995)
    1461987Renal and circulatory mechanisms in congestive heart failure.



    		+-nlKidney Int 31(6):1402-15 (1987)
    1471998The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review).



    		+-nlInt J Mol Med 1(1):17-24 (1998)
    1482002The B-type natriuretic peptide assay: a rapid test for heart failure.



    		+-nlCleve Clin J Med 69(3):243-51 (2002)
    1492007Heart failure in women is different than in men; should treatment be different?



    		+-nlCleve Clin J Med 74(6):423-4, 426, 429-35 (2007)
    1502004Cellular basis for therapeutic choices in heart failure.



    		+-nlCirculation 110(17):2559-61 (2004) Opie LH
    1512005Urocortin: advancing the neurohumoral hypothesis of heart failure.



    		+-nlCirculation 112(23):3544-6 (2005)
    1522011How to treat stage D heart failure? - When to implant left ventricular assist devices in the era of continuous flow pumps?-.



    		+-nlCirc J 75(9):2038-45 (2011)
    1532011Careful echocardiographic analysis of right ventricular function as a long-term prognostic variable in systolic heart failure.



    		+-nlCirc J 75(9):2054-5 (2011) Atluri P
    1542010The future of pharmacological therapy for heart failure.



    		+-nlCirc J 74(5):809-17 (2010)
    1552010Waon therapy for cardiovascular disease: innovative therapy for the 21st century.



    		+-nlCirc J 74(4):617-21 (2010)
    1562009Global gene expression profiling in the failing myocardium.



    		+-nlCirc J 73(9):1568-76 (2009)
    1572011Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.



    		+-nlJ Biomed Biotechnol 2011(-):729497 (2011)
    1582010Mitochondria in heart failure.



    		+-nlCardiovasc Res 88(1):40-50 (2010)
    1592008Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?



    		+-nlCardiovasc Res 77(2):302-14 (2008)
    1602008Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.



    		+-nlEur Heart J 29(9):1147-59 (2008)
    1612008Modulation of cardiac contractility. A potential treatment of heart failure?



    		+-nlEur Heart J 29(8):961-3 (2008) Daubert JC
    1622006Sudden death prevention in heart failure.



    		+-nlRev Port Cardiol 25(7-8):727-62 (2006)
    1632004Energy metabolism in heart failure.



    		+-nlJ Physiol 555(Pt 1):1-13 (2004)
    1642008Beta blockers in systolic heart failure.



    		+-nlAust Fam Physician 37(3):137-9 (2008)
    1652007Imaging of the failing heart.



    		+-nlScand J Surg 96(2):96-101 (2007)
    1662007Magnetic resonance imaging of the failing heart.



    		+-nlScand J Surg 96(2):102-6 (2007)
    1672010New biomarkers in heart failure: applications in diagnosis, prognosis and guidance of therapy.



    		+-nlRev Esp Cardiol 63(6):635-9 (2010)
    1682011Prognosis for patients with heart failure with preserved ejection fraction. Is it the same as low ejection fraction?



    		+-nlRev Esp Cardiol 64(8):646-8 (2011)
    1692009Cardiovascular translational medicine (III). Genomics and proteomics in heart failure research.



    		+-nlRev Esp Cardiol 62(3):305-13 (2009)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.